736
Views
6
CrossRef citations to date
0
Altmetric
Articles

Injecting and Rejecting, Framing and Failing

The HPV vaccine and the subjectification of citizens' identities

Pages 1071-1089 | Published online: 13 Feb 2014
 

Abstract

This paper seeks to examine how female subjectivities are privileged by Canadian human papillomavirus (HPV) vaccination discourse and, in turn, how homosexual male subjectivities are displaced. Employing a Critical Discourse Analysis approach, I analyze selected HPV vaccination (HPVV) promotional materials, and depict the discursive strategies which privilege and exclude gendered subjectivities. My critical analysis is influenced by feminist linguistic works that seek to uncover the discursive constructions around sexuality, gender and identity, and the discursive strategies used to communicate ideas about sexual health risks and responsible citizenship. In addition, I adopt feminist theories of knowledge and power to rethink the discursive representations of some bodies and subjectivities as normal, and Others as unintelligible within HPVV discourse in today's neoliberal time.

View correction statement:
Erratum

Notes

1. Medical Sociologist Steven Epstein has published on the erasure of the link between the HPV vaccine and gay men's health within public debate around the vaccine. In his book chapter, “The Great Undiscussable: Anal Cancer, HPV, and Gay Men's Health” (Citation2010), Epstein notes that the desexualization of the vaccine within public health and pharmaceutical marketing has fostered a silence around gay men and gay sex, and steered the conversation away from gay men's risks of HPV diseases such as anal and penile cancer. Epstein's contributions are noteworthy, yet primarily descriptive rather than theoretical in nature, and do not utilize a critical discourse analysis approach.

2. Health Canada is the Federal department responsible for the national public health of Canadians.

3. Gardasil® was initially approved for use in females aged between nine and twenty-six years. As of April 2011, Gardasil® is authorized for use in females between nine and forty-five years of age (PHAC, Citation2012).

4. Since this paper was written, the provinces of Prince Edward Island and Alberta have announced their intention to extend their HPV vaccination programs to school-age boys (SOGC Citation2013).

Additional information

Notes on contributors

Nicole Charles

Nicole Charles is a PhD candidate in the Women and Gender Studies Institute at the University of Toronto. Her interdisciplinary research interests include transnational feminism, medical anthropology, biomedical technologies, and claims to citizenship. E-mail: [email protected]

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 391.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.